UY32127A - Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación - Google Patents
Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparaciónInfo
- Publication number
- UY32127A UY32127A UY0001032127A UY32127A UY32127A UY 32127 A UY32127 A UY 32127A UY 0001032127 A UY0001032127 A UY 0001032127A UY 32127 A UY32127 A UY 32127A UY 32127 A UY32127 A UY 32127A
- Authority
- UY
- Uruguay
- Prior art keywords
- powder
- reduced
- processes
- containing nicotine
- preparation procedures
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Un granulado que contiene nicotina, reducido en polvo, que comprende una mezcla homogénea de nicotina o un derivado de nicotina farmacéuticamente aceptable y un excipiente. El granulado tiene un tamaño de partícula de al menos 150 um. Método para la preparación de un granulado que contiene nicotina para la preparación de productos farmacéuticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08016336A EP2177213B1 (en) | 2008-09-17 | 2008-09-17 | Nicotine-containing granulate |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32127A true UY32127A (es) | 2010-04-30 |
Family
ID=40091848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032127A UY32127A (es) | 2008-09-17 | 2009-09-17 | Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación |
Country Status (17)
Country | Link |
---|---|
US (1) | US10413512B2 (es) |
EP (1) | EP2177213B1 (es) |
AR (1) | AR073604A1 (es) |
AU (1) | AU2009294964B2 (es) |
CA (1) | CA2734402C (es) |
DK (1) | DK2177213T3 (es) |
ES (1) | ES2401912T3 (es) |
HR (1) | HRP20130161T1 (es) |
MX (1) | MX2011002696A (es) |
NZ (1) | NZ591198A (es) |
PA (1) | PA8842701A1 (es) |
PL (1) | PL2177213T3 (es) |
PT (1) | PT2177213E (es) |
SI (1) | SI2177213T1 (es) |
UY (1) | UY32127A (es) |
WO (1) | WO2010031536A1 (es) |
ZA (1) | ZA201101123B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2198865T1 (sl) * | 2008-12-19 | 2012-02-29 | Siegfried Ltd | Nikotin vsebujoč proizvod |
WO2014138603A1 (en) | 2013-03-07 | 2014-09-12 | Amneal Pharmaceuticals, LLC | Stabilization of moisture-sensitive drugs |
US11779045B2 (en) | 2013-10-03 | 2023-10-10 | Altria Client Services Llc | Dissolvable-chewable exhausted-tobacco tablet |
ES2842585T3 (es) * | 2013-10-03 | 2021-07-14 | Altria Client Services Llc | Pastilla para chupar |
US10105320B2 (en) * | 2013-10-03 | 2018-10-23 | Altria Client Services | Soluble fiber lozenge |
US10244786B2 (en) | 2013-10-03 | 2019-04-02 | Altria Client Services Llc | Tobacco lozenge |
US9351936B2 (en) | 2013-10-03 | 2016-05-31 | Altria Client Services Llc | Nicotine lozenge |
US9999243B2 (en) | 2013-10-03 | 2018-06-19 | Altria Client Services Llc | Exhausted tobacco lozenge |
CA2998422A1 (en) * | 2015-09-14 | 2017-03-23 | Merck Patent Gmbh | Formulation having controlled, delayed release of active ingredient |
EP3445344B1 (en) | 2016-04-21 | 2020-08-19 | Fertin Pharma A/S | Nicotine delivery product, related uses and oral dosage forms, and methods of production |
EP3641731A1 (en) | 2017-06-23 | 2020-04-29 | Fertin Pharma A/S | Nicotine pouch |
CA3085063C (en) * | 2017-12-08 | 2024-05-21 | Fertin Pharma A/S | Solid oral nicotine formulation |
EP3720418B1 (en) | 2017-12-08 | 2021-08-04 | Fertin Pharma A/S | Nicotine tablet |
PL3993646T3 (pl) | 2019-07-05 | 2023-12-27 | Swedish Match North Europe Ab | Doustny produkt nikotynowy w saszetce, zawierający materiał wypełniający obejmujący cząstki zawierające nikotynę |
PL4061155T3 (pl) | 2019-11-20 | 2024-01-29 | Swedish Match North Europe Ab | Doustny produkt nikotynowy w saszetce, zawierający materiał wypełniający zawierający cząstki nikotyny |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US11672862B2 (en) * | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US20220313678A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Spray dried nicotine for inclusion in oral products |
US20220313614A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Encapsulated nicotine granules and methods of preparation thereof |
US20220354785A1 (en) * | 2021-04-22 | 2022-11-10 | Nicoventures Trading Limited | Oral lozenge products |
CN114304712A (zh) * | 2021-12-17 | 2022-04-12 | 深圳市元雾科技有限公司 | 一种液体高负载的尼古丁***制品颗粒及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI104787B (fi) | 1989-06-07 | 2000-04-14 | Xyrofin Oy | Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi |
SE8904295D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Smoking substitute |
US5135753A (en) * | 1991-03-12 | 1992-08-04 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
US6276917B1 (en) * | 1999-01-28 | 2001-08-21 | Botanicals International | Powder processing apparatus |
FR2792200B3 (fr) * | 1999-04-16 | 2001-06-08 | Unicliffe Ltd | Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer |
DE19943496C1 (de) | 1999-09-10 | 2001-05-17 | Suedzucker Ag | Direkt verpressbarer Rohstoff für Komprimate |
WO2002076605A1 (de) | 2001-03-23 | 2002-10-03 | Symrise Gmbh & Co. Kg | Verfahren zur herstellung von einkapselungen |
WO2004056363A2 (en) | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
US20070269492A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
WO2008012071A2 (en) | 2006-07-24 | 2008-01-31 | Antares Pharma Ipl Ag | Pharmaceutical compositions of nicotine and methods of use thereof |
-
2008
- 2008-09-17 ES ES08016336T patent/ES2401912T3/es active Active
- 2008-09-17 SI SI200830890T patent/SI2177213T1/sl unknown
- 2008-09-17 PL PL08016336T patent/PL2177213T3/pl unknown
- 2008-09-17 EP EP08016336A patent/EP2177213B1/en active Active
- 2008-09-17 PT PT80163363T patent/PT2177213E/pt unknown
- 2008-09-17 DK DK08016336.3T patent/DK2177213T3/da active
-
2009
- 2009-09-16 AU AU2009294964A patent/AU2009294964B2/en active Active
- 2009-09-16 WO PCT/EP2009/006676 patent/WO2010031536A1/en active Application Filing
- 2009-09-16 MX MX2011002696A patent/MX2011002696A/es active IP Right Grant
- 2009-09-16 US US13/058,769 patent/US10413512B2/en active Active
- 2009-09-16 CA CA2734402A patent/CA2734402C/en active Active
- 2009-09-16 NZ NZ591198A patent/NZ591198A/en unknown
- 2009-09-17 AR ARP090103574A patent/AR073604A1/es unknown
- 2009-09-17 UY UY0001032127A patent/UY32127A/es not_active Application Discontinuation
- 2009-09-17 PA PA20098842701A patent/PA8842701A1/es unknown
-
2011
- 2011-02-11 ZA ZA2011/01123A patent/ZA201101123B/en unknown
-
2013
- 2013-02-25 HR HRP20130161AT patent/HRP20130161T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ES2401912T3 (es) | 2013-04-25 |
SI2177213T1 (sl) | 2013-03-29 |
HRP20130161T1 (hr) | 2013-03-31 |
AR073604A1 (es) | 2010-11-17 |
PA8842701A1 (es) | 2010-04-21 |
US20110165253A1 (en) | 2011-07-07 |
PT2177213E (pt) | 2013-02-21 |
AU2009294964A1 (en) | 2010-03-25 |
MX2011002696A (es) | 2011-04-05 |
NZ591198A (en) | 2012-03-30 |
AU2009294964B2 (en) | 2012-12-13 |
ZA201101123B (en) | 2012-04-25 |
WO2010031536A1 (en) | 2010-03-25 |
US10413512B2 (en) | 2019-09-17 |
PL2177213T3 (pl) | 2013-08-30 |
EP2177213B1 (en) | 2013-01-02 |
CA2734402C (en) | 2013-05-14 |
DK2177213T3 (da) | 2013-02-11 |
EP2177213A1 (en) | 2010-04-21 |
CA2734402A1 (en) | 2010-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32127A (es) | Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación | |
UY30537A1 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
NI201600093A (es) | Formulación compuesta para administración oral que comprende ezetimibe y rosuvastatina | |
AR089578A1 (es) | Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion | |
TWI265812B (en) | Pharmaceutical safety dosage forms | |
CY1111887T1 (el) | Απαραβιαστες φαρμακευτικες μορφες δοσολογιας δια του στοματος περιλαμβανουσες ενα οπιουχο αναλγητικο | |
AR062509A1 (es) | Proceso para preparar comprimidos de dihidrocloruro de pramipexol | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
CL2008002394A1 (es) | Depsipeptido ciclico, o derivados, inhibidores de calicreína 7, obtenidos desde chondromyces crocatus, metodo de obtencion y usos terapeuticos. | |
TW200700062A (en) | Pharmaceutical compositions | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
AR095159A2 (es) | Una composición farmacéutica en forma de cápsula para administración oral | |
UA96622C2 (ru) | Твердые лекарственные формы, которые содержат алискирен, изготовленные способом сухого гранулирования | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
AR065528A1 (es) | Forma de dosificacion que comprende 6-(3- coclobutil -2,3,4,5- tetrahidro -1h - benzo (d) azepin -7-iloxi)-n - metil- nicotinamida , metodo para producirla, su uso para preparar un medicamento y solucion o suspension que los comprende | |
AR066000A1 (es) | Procedimiento para preparar comprimidos de dihidrocloruro de pramipexol | |
MX2017015322A (es) | Composicion farmaceutica oral de isotretinoin. | |
CL2016000183A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
UY30126A1 (es) | Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones | |
UA97355C2 (ru) | Фармацевтическая композиция, включающая монтелукаст | |
MD3121F1 (en) | Method of viral hepatitis B prophylaxis | |
CL2016000182A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
CL2019001424A1 (es) | Comprimido compuesto oral que comprende ezetimiba y rosuvastatina. | |
PE20141817A1 (es) | Formulaciones farmaceuticas estabilizadas de un potente inhibidor de hcv | |
CO2017011220A2 (es) | Proceso para la fabricación de mezclas de polvo seco |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181114 |